2022 ICD-10-CM Code D39.10
Neoplasm of uncertain behavior of unspecified ovary
Valid for Submission
ICD-10: | D39.10 |
Short Description: | Neoplasm of uncertain behavior of unspecified ovary |
Long Description: | Neoplasm of uncertain behavior of unspecified ovary |
Code Classification
D39.10 is a billable diagnosis code used to specify a medical diagnosis of neoplasm of uncertain behavior of unspecified ovary. The code D39.10 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code D39.10 might also be used to specify conditions or terms like borderline epithelial tumor of ovary, granulosa cell tumor of ovary, gynandroblastoma of ovary, neoplasm of low malignant potential behavior of ovary, neoplasm of uncertain behavior of ovary , ovarian gonadoblastoma, etc.
The code D39.10 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.
Unspecified diagnosis codes like D39.10 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D39.10 are found in the index:
- - Adenofibroma
- - endometrioid - D27.9
- - borderline malignancy - D39.10
- - endometrioid - D27.9
- - Androblastoma
- - unspecified site
- - female - D39.10
- - unspecified site
- - Arrhenoblastoma
- - unspecified site
- - female - D39.10
- - unspecified site
- - Cyst (colloid) (mucous) (simple) (retention)
- - multilocular (ovary) - D39.10
- - ovary, ovarian (twisted) - N83.20
- - multilocular - D39.10
- - Gonadoblastoma
- - unspecified site
- - female - D39.10
- - unspecified site
- - Gonocytoma
- - unspecified site
- - female - D39.10
- - unspecified site
- - Gynandroblastoma
- - unspecified site
- - female - D39.10
- - unspecified site
- - Papilloma - See Also: Neoplasm, benign, by site;
- - serous surface
- - borderline malignancy
- - unspecified site - D39.10
- - borderline malignancy
- - serous surface
- - Tumor - See Also: Neoplasm, unspecified behavior, by site;
- - Leydig cell - See: Neoplasm, uncertain behavior, by site;
- - unspecified site
- - female - D39.10
- - unspecified site
- - Leydig cell - See: Neoplasm, uncertain behavior, by site;
Code Edits
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:
- Diagnoses for females only - The Medicare Code Editor detects inconsistencies between a patient’s sex and any diagnosis on the patient’s record, these edits apply to FEMALES only .
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Borderline epithelial tumor of ovary
- Granulosa cell tumor of ovary
- Gynandroblastoma of ovary
- Neoplasm of low malignant potential behavior of ovary
- Neoplasm of uncertain behavior of ovary
- Ovarian gonadoblastoma
- Virilizing ovarian tumor
Diagnostic Related Groups - MS-DRG Mapping
The ICD-10 code D39.10 is grouped in the following groups for version MS-DRG V39.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2021 through 09/30/2022.
MS-DRG | MS-DRG Title | MCD | Relative Weight |
---|---|---|---|
736 | UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC | 13 | 4.2582 |
737 | UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC | 13 | 2.0582 |
738 | UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC | 13 | 1.4766 |
739 | UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC | 13 | 3.8217 |
740 | UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC | 13 | 1.8 |
741 | UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC | 13 | 1.2795 |
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Convert D39.10 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code D39.10 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
- 236.2 - Unc behav neo ovary (Approximate Flag)
Information for Patients
Ovarian Disorders
The ovaries are part of the female reproductive system. Women have two ovaries, one on each side of the uterus. Each ovary is about the size and shape of an almond.
The ovaries produce and store a woman's eggs. During ovulation, an ovary releases an egg. If that egg is fertilized by a sperm, a pregnancy can occur. Ovaries also make the female hormones estrogen and progesterone. When a woman goes through menopause, her ovaries stop making those hormones and releasing eggs.
Problems with the ovaries include
- Ovarian cancer
- Ovarian cysts and polycystic ovary syndrome
- Primary ovarian insufficiency
- Ovarian torsion, a twisting of the ovary
[Learn More in MedlinePlus]
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)